Daily BriefsECM

Daily Brief ECM: Lion Heart Studio Pre-IPO – The Positives – Got One Hit and more

In today’s briefing:

  • Lion Heart Studio Pre-IPO – The Positives – Got One Hit
  • Lohia Corp Pre-IPO Tearsheet
  • SAMG Entertainment IPO Preview
  • Giant Biogene Pre-IPO – PHIP Updates – Sales Growing Faster but so Have Marketing Spends

Lion Heart Studio Pre-IPO – The Positives – Got One Hit

By Sumeet Singh

  • Lionheart Studio (426630 KS), a game development studio based in South Korea,  aims to raise around US$420m via its South Korean IPO.
  • The company is majority owned by Kakao Games Corp (293490 KS), which after having recently hiked its stake, owned 54.94% of the company prior to listing.  
  • In this note, we will talk about the positive aspects of the deal.

Lohia Corp Pre-IPO Tearsheet

By Ethan Aw

  • Lohia Corp (1638860D IN) is looking to raise about US$183m in its upcoming India IPO. The deal will be run by ICICI Securities, HSBC, IIFL Securities and Motilal Oswal.
  • Lohia Corp is the market leader in India for end-to-end manufacturing solutions within the machine segment for the Raffia industry in Fiscal 2022, according to Frost & Sullivan. 
  • In addition to machines for the Raffia industry, it also manufactures spin-draw-wind machines (LOFIL) for polypropylene (PP) multifilament yarn that is used in upholstery, among others.

SAMG Entertainment IPO Preview

By Douglas Kim

  • SAMG Entertainment is getting ready for an IPO on the KOSDAQ market. SAMG Entertainment is a leading children animation and digital contents focused entertainment company targeting young children.
  • The IPO offering amount is from 37.8 billion won to 46.7 billion won. The book building for the institutional investors starts on 1 November.
  • The company operates 42 Youtube channels including 15 domestic channels and 27 overseas channels. The total number of subscribers for these 42 Youtube channels exceeds 39 million.

Giant Biogene Pre-IPO – PHIP Updates – Sales Growing Faster but so Have Marketing Spends

By Sumeet Singh

  • Giant Biogene Holding (GBH HK) aims to raise around US$500m in its Hong Kong IPO.
  • GB is a leader in the bioactive ingredient-based professional skin treatment product industry in China.
  • We had looked at the company’s past performance in  our previous notes. In this note, we’ll talk about its PHIP updates.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars